Terms: = Cervical cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL
33 results:
1. HPV DNA Testing and Mobile Colposcopy for cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
Effah K; Anthony R; Tekpor E; Amuah JE; Wormenor CM; Tay G; Kraa SEY; Katso AM; Akonnor CA; Kemawor S; Danyo S; Atuguba BH; Essel NOM; Akakpo PK
Cancer Control; 2024; 31():10732748241244678. PubMed ID: 38563112
[TBL] [Abstract] [Full Text] [Related]
2. Macrofollicular Architecture in Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Pitfall in Thyroid Practice.
Yadav S; Kandasamy D; Damle N; Goel R; Chumber S; Sharma MC; Boruah M; Agarwal S
Head Neck Pathol; 2023 Dec; 17(4):899-909. PubMed ID: 37775618
[TBL] [Abstract] [Full Text] [Related]
3. Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis.
Prem K; Choi YH; Bénard É; Burger EA; Hadley L; Laprise JF; Regan MC; Drolet M; Sy S; Abbas K; Portnoy A; Kim JJ; Brisson M; Jit M
BMC Med; 2023 Aug; 21(1):313. PubMed ID: 37635227
[TBL] [Abstract] [Full Text] [Related]
4. Failure to follow up abnormal test results associated with cervical cancer in primary and ambulatory care: a systematic review.
Martinez-Gutierrez J; Chima S; Boyd L; Sherwani A; Drosdowsky A; Karnchanachari N; Luong V; Reece JC; Emery J
BMC Cancer; 2023 Jul; 23(1):653. PubMed ID: 37438686
[TBL] [Abstract] [Full Text] [Related]
5. High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer.
Yazaki S; Kojima Y; Yoshida H; Takamizawa S; Kitadai R; Nishikawa T; Shimoi T; Sudo K; Saito A; Okuma HS; Tanioka M; Noguchi E; Uno M; Ishikawa M; Kato T; Fujiwara Y; Ohe Y; Yonemori K
J Gynecol Oncol; 2022 Nov; 33(6):e82. PubMed ID: 36245230
[TBL] [Abstract] [Full Text] [Related]
6. Modelling cervical cancer elimination using single-visit screening and treatment strategies in the context of high HIV prevalence: estimates for KwaZulu-Natal, South Africa.
Rao DW; Bayer CJ; Liu G; Chikandiwa A; Sharma M; Hathaway CL; Tan N; Mugo N; Barnabas RV
J Int AIDS Soc; 2022 Oct; 25(10):e26021. PubMed ID: 36225139
[TBL] [Abstract] [Full Text] [Related]
7. Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022.
Prudden HJ; Achilles SL; Schocken C; Broutet N; Canfell K; Akaba H; Basu P; Bhatla N; Chirenje ZM; Delany-Moretlwe S; Denny L; Gamage DG; Herrero R; Hutubessy R; Villa LL; Murillo R; Schiller JT; Stanley M; Temmerman M; Zhao F; Ogilvie G; Kaslow DC; Dull P; Gottlieb SL;
Vaccine; 2022 Sep; 40(41):5843-5855. PubMed ID: 36008233
[TBL] [Abstract] [Full Text] [Related]
8. Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors.
Xu B; Viswanathan K; Umrau K; Al-Ameri TAD; Dogan S; Magliocca K; Ghossein RA; Cipriani NA; Katabi N
Histopathology; 2022 Nov; 81(5):670-679. PubMed ID: 35974431
[TBL] [Abstract] [Full Text] [Related]
9. Histopathological Characteristics of N1b Papillary Thyroid Carcinoma are Associated with Risk of Recurrence.
Carmel Neiderman NN; Duek I; Kuzmenko B; Ringel B; Warshavsky A; Muhanna N; Horowitz G; Fliss DM
World J Surg; 2022 Aug; 46(8):1917-1925. PubMed ID: 35543736
[TBL] [Abstract] [Full Text] [Related]
10. Now or later: Health impacts of delaying single-dose HPV vaccine implementation in a high-burden setting.
Burger EA; Laprise JF; Sy S; Regan MC; Prem K; Jit M; Brisson M; Kim JJ
Int J Cancer; 2022 Nov; 151(10):1804-1809. PubMed ID: 35512109
[TBL] [Abstract] [Full Text] [Related]
11. etv6-NTRK3-positive parotid mammary analogue secretory carcinoma: a case report.
Rodríguez Cobo J; Lazuén Fernández S; Mayorga Fernández MM; Gómez Román J; Freire Salinas J; Rodríguez Duque MS; Vallejo Secadas C; Álvarez Gama J; Ibaseta Fidalgo E; Medina Del Valle J
Rom J Morphol Embryol; 2021; 62(1):309-312. PubMed ID: 34609437
[TBL] [Abstract] [Full Text] [Related]
12. Modelling the impact of prevention strategies on cervical cancer incidence in South Africa.
van Schalkwyk C; Moodley J; Welte A; Johnson LF
Int J Cancer; 2021 Oct; 149(8):1564-1575. PubMed ID: 34164807
[TBL] [Abstract] [Full Text] [Related]
13. The Clinicopathological Results of Thyroid cancer With BRAFV600E Mutation in the Young Population of Fukushima.
Iwadate M; Mitsutake N; Matsuse M; Fukushima T; Suzuki S; Matsumoto Y; Ookouchi C; Mizunuma H; Nakamura I; Nakano K; Sakamoto A; Hirokawa M; Ito M; Naganuma H; Hashimoto Y; Shimura H; Yamashita S; Suzuki S
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32827026
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
Chu YH; Wirth LJ; Farahani AA; Nosé V; Faquin WC; Dias-Santagata D; Sadow PM
Mod Pathol; 2020 Dec; 33(12):2458-2472. PubMed ID: 32737449
[TBL] [Abstract] [Full Text] [Related]
15. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic etv6-NTRK3 gene fusion.
Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
Ann Oncol; 2019 Nov; 30 Suppl 8():viii31-viii35. PubMed ID: 32223937
[TBL] [Abstract] [Full Text] [Related]
16. [Comparison of progression-free and overall survival between endometrial cancer patients treated with laparoscopic and open surgical techniques].
Póka R; Baradács I
Orv Hetil; 2020 Mar; 161(10):382-388. PubMed ID: 32115990
[TBL] [Abstract] [Full Text] [Related]
17. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
[TBL] [Abstract] [Full Text] [Related]
18. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic etv6-NTRK3 gene fusion.
Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
Ann Oncol; 2019 Nov; 30(Suppl_8):viii31-viii35. PubMed ID: 31738425
[TBL] [Abstract] [Full Text] [Related]
19. A Case of Papillary Thyroid Carcinoma and Kostmann Syndrome: A Genomic Theranostic Approach for Comprehensive Treatment.
Han S; Ehrhardt J; Shukla S; Elkbuli A; Nikiforov YE; Gulec SA
Am J Case Rep; 2019 Jul; 20():1027-1034. PubMed ID: 31308356
[TBL] [Abstract] [Full Text] [Related]
20. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
[TBL] [Abstract] [Full Text] [Related]
[Next]
